Back to Search
Start Over
Efficacy and Treatment Persistence of First-line Natalizumab vs. Interferon beta or Glatiramer Acetate in relapsing MS
- Authors :
- Butzkueven, H.
Spelman, T.
Kalincik, T.
Jokubaitis, V.
Zhang, A.
Pellegrini, F.
Wiendl, H.
Belachew, S.
Hyde, R.
Verheul, F.
Lugaresi, A.
Havrdova, E.
Horakova, D.
Grammond, P.
Duquette, P.
Prat, A.
Iuliano, G.
Terzi, M.
Izquierdo, G.
Hupperts, R.
Boz, C.
Pucci, E.
Giuliani, G.
Sola, P.
La Spitaleri, D.
Lechner-Scott, J.
Bergamaschi, R.
Grand-Maison, F.
Granella, F.
Kappos, L.
Trojano, M.
MSBase Investigators
Top, Investigators
- Source :
- ResearcherID
Details
- Database :
- OpenAIRE
- Journal :
- ResearcherID
- Accession number :
- edsair.dedup.wf.001..81d216a6faa4f815cd1e51cca15e772d